4/A

PRIMARY DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: January 29, 2014
Period of Report: November 26, 2013
Accession Number: 0001250853-14-000034

View Document ↗ View on SEC.gov ↗